Follow
Kevin K. Lin
Kevin K. Lin
Head of Translational Medicine, Revolution Medicines
Verified email at revmed.com - Homepage
Title
Cited by
Cited by
Year
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
RL Coleman, AM Oza, D Lorusso, C Aghajanian, A Oaknin, A Dean, ...
The Lancet 390 (10106), 1949-1961, 2017
16042017
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, ...
The lancet oncology 18 (1), 75-87, 2017
11592017
Deep learning of binary hash codes for fast image retrieval
K Lin, HF Yang, JH Hsiao, CS Chen
Proceedings of the IEEE conference on computer vision and pattern …, 2015
7452015
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC
AO Walter, RTT Sjin, HJ Haringsma, K Ohashi, J Sun, K Lee, ...
Cancer discovery 3 (12), 1404-1415, 2013
7042013
End-to-end human pose and mesh reconstruction with transformers
K Lin, L Wang, Z Liu
Proceedings of the IEEE/CVF conference on computer vision and pattern …, 2021
5972021
Adversarial ranking for language generation
K Lin, D Li, X He, Z Zhang, MT Sun
Advances in neural information processing systems 30, 2017
4182017
Learning compact binary descriptors with unsupervised deep neural networks
K Lin, J Lu, CS Chen, J Zhou
Proceedings of the IEEE conference on computer vision and pattern …, 2016
4172016
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian …
O Kondrashova, M Nguyen, K Shield-Artin, AV Tinker, NNH Teng, ...
Cancer discovery 7 (9), 984-998, 2017
3652017
Supervised learning of semantics-preserving hash via deep convolutional neural networks
HF Yang, K Lin, CS Chen
IEEE transactions on pattern analysis and machine intelligence 40 (2), 437-451, 2017
3552017
BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
KK Lin, MI Harrell, AM Oza, A Oaknin, I Ray-Coquard, AV Tinker, ...
Cancer discovery 9 (2), 210-219, 2019
3252019
Antitumor activity and safety of the PARP inhibitor rucaparib in patients with high-grade ovarian carcinoma and a germline or somatic BRCA1 or BRCA2 mutation: Integrated …
AM Oza, AV Tinker, A Oaknin, R Shapira-Frommer, IA McNeish, ...
Gynecologic oncology 147 (2), 267-275, 2017
2532017
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
O Kondrashova, M Topp, K Nesic, E Lieschke, GY Ho, MI Harrell, ...
Nature communications 9 (1), 3970, 2018
2272018
The Grainyhead-like epithelial transactivator Get-1/Grhl3 regulates epidermal terminal differentiation and interacts functionally with LMO4
Z Yu, KK Lin, A Bhandari, JA Spencer, X Xu, N Wang, Z Lu, GN Gill, ...
Developmental biology 299 (1), 122-136, 2006
2012006
Rucaparib Monotherapy in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
RT Shroff, A Hendifar, RR McWilliams, R Geva, R Epelbaum, L Rolfe, ...
JCO precision oncology 2, 1-15, 2018
1912018
Circadian clock genes contribute to the regulation of hair follicle cycling
KK Lin, V Kumar, M Geyfman, D Chudova, AT Ihler, P Smyth, R Paus, ...
PLoS genetics 5 (7), e1000573, 2009
1902009
A randomized, phase III trial to evaluate rucaparib monotherapy as maintenance treatment in patients with newly diagnosed ovarian cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
BJ Monk, C Parkinson, MC Lim, DM O'malley, A Oaknin, MK Wilson, ...
Journal of Clinical Oncology 40 (34), 3952, 2022
1732022
Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)
EM Swisher, TT Kwan, AM Oza, AV Tinker, I Ray-Coquard, A Oaknin, ...
Nature communications 12 (1), 2487, 2021
1312021
Identification of hair cycle-associated genes from time-course gene expression profile data by using replicate variance
KK Lin, D Chudova, GW Hatfield, P Smyth, B Andersen
Proceedings of the National Academy of Sciences 101 (45), 15955-15960, 2004
1242004
Abandoned object detection via temporal consistency modeling and back-tracing verification for visual surveillance
K Lin, SC Chen, CS Chen, DT Lin, YP Hung
IEEE Transactions on Information Forensics and Security 10 (7), 1359-1370, 2015
1112015
Results of ARIEL2: A Phase 2 trial to prospectively identify ovarian cancer patients likely to respond to rucaparib using tumor genetic analysis.
IA McNeish, AM Oza, RL Coleman, CL Scott, GE Konecny, A Tinker, ...
Journal of Clinical Oncology 33 (15_suppl), 5508-5508, 2015
1012015
The system can't perform the operation now. Try again later.
Articles 1–20